Anticancer Activity and Differentially Expressed Genes in Head and Neck Cancer Cells Treated with a Novel Cyclin-Dependent Kinase Inhibitor

Publisher： Karger

E-ISSN： 1421-9794|55|5|353-362

ISSN： 0009-3157

Source： Chemotherapy, Vol.55, Iss.5, 2009-08, pp. : 353-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-Dependent Kinase Inhibitors as Marketed Anticancer Drugs: Where Are We Now? A Short Survey

By Mariaule Gaëlle Belmont Philippe

Molecules, Vol. 19, Iss. 9, 2014-09 ,pp. : 14366-14382

MDPI

Access to resources Recommend Favorite

Synergism of Cyclin-Dependent Kinase Inhibitors with Camptothecin Derivatives in Small Cell Lung Cancer Cell Lines

By Hamilton Gerhard Klameth Lukas Rath Barbara Thalhammer Theresia

Molecules, Vol. 19, Iss. 2, 2014-02 ,pp. : 2077-2088

MDPI

Access to resources Recommend Favorite

Cancer Stem Cells in Head and Neck Cancer

By Mitra Doyel Malkoski Stephen P. Wang Xiao-Jing

Cancers, Vol. 3, Iss. 1, 2011-01 ,pp. : 415-427

MDPI

Access to resources Recommend Favorite

Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma

By Baba Yuh Maeda Toyonobu Suzuki Atsuko Takada Satoshi Fujii Masato Kato Yasumasa

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 262-262

MDPI

Access to resources Recommend Favorite

A Quest for Initiating Cells of Head and Neck Cancer and Their Treatment

By Chen Chao Köberle Beate Kaufmann Andreas M. Albers Andreas E.

Cancers, Vol. 2, Iss. 3, 2010-07 ,pp. : 1528-1554

MDPI

Access to resources Recommend Favorite